|
G |
PGR |
progesterone receptor |
multiple interactions |
EXP |
erucyl amide binds to and results in decreased activity of PGR protein |
CTD |
PMID:27633901 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
increases activity |
EXP |
linoleamide analog results in increased activity of PPARG protein |
CTD |
PMID:29288688 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
oleylamide binds to and results in increased activity of AHR protein |
CTD |
PMID:27633901 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP3 protein]] |
CTD |
PMID:23747833 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] |
CTD |
PMID:23747833 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CHAT |
choline O-acetyltransferase |
increases activity |
EXP |
oleylamide results in increased activity of CHAT protein |
CTD |
PMID:12843655 |
|
NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
decreases secretion |
EXP |
oleylamide results in decreased secretion of COL1A1 protein |
CTD |
PMID:16475185 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
GABRB3 |
gamma-aminobutyric acid type A receptor subunit beta3 |
decreases response to substance |
ISO |
GABRB3 gene mutant form results in decreased susceptibility to oleylamide |
CTD |
PMID:11742254 |
|
NCBI chr15:26,543,552...26,773,763
Ensembl chr15:26,543,552...26,939,539
|
|
G |
GJB1 |
gap junction protein beta 1 |
multiple interactions |
EXP |
oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP3 protein]]; oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] |
CTD |
PMID:23747833 |
|
NCBI chr X:71,215,239...71,225,516
Ensembl chr X:71,212,811...71,225,516
|
|
G |
GJB2 |
gap junction protein beta 2 |
multiple interactions |
EXP |
oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP3 protein]]; oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] |
CTD |
PMID:23747833 |
|
NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
increases activity |
EXP |
oleylamide analog results in increased activity of PPARG protein |
CTD |
PMID:29288688 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
|
G |
EPHX1 |
epoxide hydrolase 1 |
decreases activity multiple interactions |
ISO |
propionamide analog results in decreased activity of EPHX1 protein [propionamide analog results in decreased activity of EPHX1 protein] which results in increased glutathionylation of naphthalene |
CTD |
PMID:18363382 |
|
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
|
|